0
2018
Africa Large Volume Parenterals (lvp) Market

Africa Large Volume Parenterals (LVP) Market

by Treatment Type (Fluid Balance Injections, Therapeutic Injections, and Nutritious Injections), Route of Administration (Intravenous, Intramuscular, Subcutaneous, and Other), and Capacity (100 ml, 250 ml, 500 ml, 1000 ml, and 2000 ml) - Global Opportunity Analysis and Industry Forecast, 2018-2024
Update Available On-Demand

Report Code: A04260
Pages: 85
Apr 2018 | 8825 Views
Author(s) : Amrita S, & J
Tables: 25
Charts: 23
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Africa Large Volume Parenterals (lvp) Market

Request Now !

Africa Large Volume Parenterals (LVP) Market Overview:

The Africa large volume parenterals (LVP) market was valued at $662 million in 2017, and is expected to reach $1,133 million by 2024, growing at a CAGR of 7.9% from 2018 to 2024. In terms of volume, the market garnered 291,095 thousand units in 2017, and is expected to reach 582,780 thousand units by 2024, growing with a CAGR of 10.4% from 2018 to 2024.

The growth of the Africa large volume parenterals market is driven by rise in prevalence of chronic diseases such as cancer, HIV, and other non-communicable diseases; rapid surge in number of surgeries; and rise in risk of malnutrition. However, preference for enteral route of drug administration of therapeutic & nutritional needs and high risk of infection/allergic reaction during a parenteral administration are expected to impede the market growth. Conversely, upsurge in demand for palliative care services in Africa is expected to offer opportunities for market expansion during the forecast period.

Africa Large Volume Parenterals Market Segmentation

The Africa large volume parenterals market is segmented on the basis of treatment type, route of administration, capacity, and country. On the basis of treatment type, the market is classified into fluid balance injections, therapeutic injections, and nutritious injections. Depending on route of administration, it is fragmented into intravenous, intramuscular, subcutaneous, and other routes. LVP are commercially available in 100 ml, 250 ml, 500 ml, 1000 ml, and 2000 ml bottles. Country wise, the market is analyzed across South Africa, Zimbabwe, Namibia, and rest of Africa.

Segment review

Fluid balance injection is the most commonly used treatment type, owing its wide applications such as fluid resuscitation, routine maintenance, replacement, and redistribution. Fluid resuscitation refers to the restoration of circulation to vital organs after loss of intravascular fluids due to bleeding, plasma loss, or excessive external fluid & electrolyte loss. Parenteral preparations are required by patients who cannot meet their normal fluid or electrolyte needs by oral/enteral routes. These patients need to undergo IV therapy for routine maintenance of bodily fluids and electrolytes. In addition, LVP may be needed for internal fluid distribution changes in case of edema or abnormal fluid handling by the organ systems. Fluid redistribution is required in patients who are critically ill, septic, with major cardiac, liver or renal comorbidity, or after a major surgery.

by treatment type

Based on route of administration, the market is fragmented into intravenous, intramuscular, subcutaneous, and other routes. Intravenous (IV) route is the most commonly used route, and serves as the fastest way to deliver large volume parenterals, as the drug is easily carried throughout the body with the help of circulation.

Furthermore, the market is analyzed for volume of large volume parenterals by capacity, i.e. 100 ml, 250 ml, 500 ml, 1000 ml, and 2000 ml bottles.

by route

Snapshot of South Africa large volume parenterals market

South Africa has one of the most advanced palliative care systems in Africa, as it has an extensive network of hospice organizations that provide care to people suffering from chronic and life-threatening illnesses. For instance, palliative care is required in the end stage of cancer, lung diseases, diabetes, and cardiac diseases. In addition, rise in prevalence of non-communicable diseases is expected to drive the market growth. However, according to the South African Health News Service, most of the palliative care facilities in South Africa focus on cancer and HIV patients as compared to other conditions. Thus, South African healthcare organizations are expected to expand their palliative care facilities for patients suffering from other non-communicable or life-threatening disorders, which would further propel the growth of the market.

by country

The key local players within Africa large volume parenterals market include Abacus Parenteral Drugs Limited, Erongo Med, Datlabs Private Limited, Addis Pharmaceuticals Factory PLC, Pharmacure PLC, Mascareignes Pharmaceutical Manufacturing Co. Ltd. (operates as a subsidiary of Parenteral Drug (India) Ltd.), and Adcock Ingram Holdings Ltd.

Key Benefits

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2017 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Analysis by route of administration helps to understand the various routes for administration of parenteral drugs within the body.
  • Comprehensive analysis of major countries within Africa is provided to determine the prevailing opportunities.
  • Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

Africa Large Volume Parenterals (LVP) Market Report Highlights

Aspects Details
By Treatment Type
  • Fluid Balance Injections
  • Therapeutic Injections
  • Nutritious Injections
By Route Of Administration
  • Intravenous
  • Intramuscular
  • Subcutaneous
  • Other routes
By Capacity
  • 100 ml
  • 250 ml
  • 500 ml
  • 1000 ml
  • 2000 ml
By Country
  • South Africa
  • Zimbabwe
  • Namibia
  • Rest of Africa
Key Market Players Parenteral Drugs (India) Ltd., Adcock Ingram Holdings Ltd., Pharmacure PLC, Datlabs Private Limited, Erongo Med, Addis Pharmaceutical Factory PLC., Abacus Parenteral Drugs Limited
 

Loading Table Of Content...


 
 

The adoption of large volume parenterals in Africa is expected to increase in the near future, owing to high prevalence rate of chronic disorders such as cancer, HIV/AIDS, and other non-communicable diseases. The LVP market has gained the traction among the healthcare providers, owing to rapid rise in number of surgeries. In addition, surge in risk of malnutrition in Africa significantly drives the market growth.

South Africa is expected to dominate the Africa LVP market during the analysis period. In addition, Namibia is expected to offer lucrative opportunities to market players in the coming future.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample

Purchase Full Report of
Africa Large Volume Parenterals (lvp) Market

Start reading instantly.
This Report and over 19,329+ more Reports, Available with Avenue Library. T&C*.

  • Data Pack
  • $2,074
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Apr 2019 - Apr 2020)
  • Single User
  • $2,900
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Apr 2019 - Apr 2020)
  • Five Users
  • $3,483
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Apr 2019 - Apr 2020)
  • Enterprise
    License/PDF

  • $5,858
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Apr 2019 - Apr 2020)
  • Library
    Membership

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers